This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Open Angle Glaucoma
and you are
between 40 and 85
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to compare the efficacy and safety of Trabectome versus Trabeculectomy with adjunctive Mitomycin C, combined with cataract surgery, in patients with open angle glaucoma.

Provided treatments

  • Procedure: Trabectome-IOL
  • Procedure: Trab-IOL
Tris trial is registered with FDA with number: NCT00901108. The sponsor of the trial is University of Alberta and it is looking for 19 volunteers for the current phase.
Official trial title:
Prospective Randomized Controlled Trial of Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma